[go: up one dir, main page]

PT97500A - Processo de producao de lipossomas e de preparados farmaceuticos contendo aqueles lipossomas - Google Patents

Processo de producao de lipossomas e de preparados farmaceuticos contendo aqueles lipossomas

Info

Publication number
PT97500A
PT97500A PT97500A PT9750091A PT97500A PT 97500 A PT97500 A PT 97500A PT 97500 A PT97500 A PT 97500A PT 9750091 A PT9750091 A PT 9750091A PT 97500 A PT97500 A PT 97500A
Authority
PT
Portugal
Prior art keywords
liposomes
formula
production process
pharmaceutical preparations
pnn
Prior art date
Application number
PT97500A
Other languages
English (en)
Other versions
PT97500B (pt
Inventor
Hansjorg Eibl
Clemens Unger
Petra Kaufmann-Kolle
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of PT97500A publication Critical patent/PT97500A/pt
Publication of PT97500B publication Critical patent/PT97500B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PT97500A 1990-04-27 1991-04-26 Processo de producao de lipossomas e de preparados farmaceuticos contendo aqueles lipossomas PT97500B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4013632A DE4013632A1 (de) 1990-04-27 1990-04-27 Liposomen mit positiver ueberschussladung

Publications (2)

Publication Number Publication Date
PT97500A true PT97500A (pt) 1992-01-31
PT97500B PT97500B (pt) 1998-08-31

Family

ID=6405307

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97500A PT97500B (pt) 1990-04-27 1991-04-26 Processo de producao de lipossomas e de preparados farmaceuticos contendo aqueles lipossomas

Country Status (11)

Country Link
EP (1) EP0526531B1 (pt)
JP (1) JPH05506661A (pt)
AT (1) ATE107503T1 (pt)
AU (1) AU643282B2 (pt)
CA (1) CA2081119A1 (pt)
DE (2) DE4013632A1 (pt)
DK (1) DK0526531T3 (pt)
ES (1) ES2056648T3 (pt)
IE (1) IE62548B1 (pt)
PT (1) PT97500B (pt)
WO (1) WO1991016880A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH087409B2 (ja) * 1988-10-03 1996-01-29 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料の処理方法
US5264618A (en) * 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
DE4208527A1 (de) * 1992-03-17 1993-09-23 Max Planck Gesellschaft Liposomen mit negativer ueberschussladung
US5552155A (en) * 1992-12-04 1996-09-03 The Liposome Company, Inc. Fusogenic lipsomes and methods for making and using same
WO1994027435A1 (en) 1993-06-01 1994-12-08 Life Technologies, Inc. Genetic immunization with cationic lipids
EP0638639B1 (en) * 1993-08-10 2000-04-12 Akzo Nobel N.V. Biodegradable fabric softening composition
AU689479B2 (en) * 1994-04-12 1998-04-02 Transave, Inc. Fusogenic liposomes and methods of making and using same
US5429755A (en) * 1994-06-16 1995-07-04 Lever Brothers Company Fabric conditioning molecules derived from glycerol and betaine
EP0728737B1 (en) * 1995-02-24 1998-10-28 Kao Corporation Quaternary ammonium salt, method for production thereof, and its use within a softener composition
EP0863749A2 (en) 1995-11-30 1998-09-16 Vical Incorporated Complex cationic lipids
DE19835611A1 (de) * 1998-08-06 2000-02-10 Max Planck Gesellschaft Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten
EP1261620A2 (en) * 2000-02-07 2002-12-04 Roche Diagnostics Corporation Cationic amphiphiles for use in nucleic acid transfection
ITMI20032185A1 (it) * 2003-11-12 2005-05-13 Chemi Spa Processo per la sintesi di lipidi cationici.
DE102004057303A1 (de) * 2004-11-26 2006-06-01 Merck Patent Gmbh Stabile Kristallmodifikationen von DOTAP Chlorid
DK2068886T3 (da) * 2006-10-03 2013-11-18 Tekmira Pharmaceuticals Corp Lipidholdige præparater
AU2011261247B2 (en) * 2010-06-03 2016-08-25 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
JP6159254B2 (ja) * 2010-10-06 2017-07-12 フンダシオ インスティトゥト デ レセルカ ビオメディカ(イエレベ バルセロナ) 乳がん転移の診断、予後診断、および処置のための方法
CN103547560A (zh) 2011-05-20 2014-01-29 默克专利股份有限公司 稳定的dotap氯化物晶体变体
JP2013043885A (ja) * 2011-08-26 2013-03-04 Kansai Bunri Sogo Gakuen デヒドロアミノ酸含有グリセロール誘導体
CA3165769A1 (en) 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
EP2650682A1 (en) 2012-04-09 2013-10-16 Fundació Privada Institut de Recerca Biomèdica Method for the prognosis and treatment of cancer metastasis
KR102571924B1 (ko) 2016-05-25 2023-08-28 인바이오모션 에스.엘. c-MAF 상태에 기초한 유방암의 치료
US11654153B2 (en) 2017-11-22 2023-05-23 Inbiomotion S.L. Therapeutic treatment of breast cancer based on c-MAF status
KR102054401B1 (ko) 2018-03-26 2019-12-10 주식회사 엔지켐생명과학 1,2-디아실글리세롤 화합물, 그 제조방법 및 이를 유효성분으로 함유하는 면역조절제
JP7685776B2 (ja) * 2022-11-08 2025-05-30 美洛生物科技股▲ふん▼有限公司 カチオン性脂質及びその使用
WO2024253473A1 (ko) 2023-06-07 2024-12-12 포항공과대학교 산학협력단 핵산 치료제에 사용되는 기능성 지질 라이브러리를 합성하기 위한 단일 연속 유동 합성 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2752553C2 (de) * 1977-11-24 1985-07-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue phospholipidartige Verbindungen, ihre Verwendung zur Herstellung von Pflanzenhybriden und Verfahren zu ihrer Herstellung
AU5632880A (en) * 1979-04-30 1980-11-06 Brown, G. Convertible sleeping and seating apparatus
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
ZA8681B (en) * 1985-01-07 1987-08-26 Syntex Inc 1,2-dialkoxy-omega-trialkylammonium cationic surfactants
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
JPS632921A (ja) * 1986-06-20 1988-01-07 Yamanouchi Pharmaceut Co Ltd リポソ−ム製剤

Also Published As

Publication number Publication date
AU643282B2 (en) 1993-11-11
ATE107503T1 (de) 1994-07-15
IE62548B1 (en) 1995-02-08
DE4013632A1 (de) 1991-10-31
IE911427A1 (en) 1991-11-06
PT97500B (pt) 1998-08-31
ES2056648T3 (es) 1994-10-01
AU7770291A (en) 1991-11-27
DK0526531T3 (da) 1994-08-22
DE59102030D1 (de) 1994-07-28
CA2081119A1 (en) 1991-10-28
JPH05506661A (ja) 1993-09-30
EP0526531A1 (de) 1993-02-10
EP0526531B1 (de) 1994-06-22
WO1991016880A1 (de) 1991-11-14

Similar Documents

Publication Publication Date Title
PT97500A (pt) Processo de producao de lipossomas e de preparados farmaceuticos contendo aqueles lipossomas
CA2078790A1 (en) 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
ATE176664T1 (de) 2-propylvaleriansäure und 2-propylvalerian- säureamid-derivate und deren verwendung als antikonvulsive mittel
TR200102038T2 (tr) Amid bileşenler
ATE63124T1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
FR2719041B1 (fr) Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
EA200100983A1 (ru) Производные 13-метилэритромицина
FR2358418A1 (fr) Nouveaux polygalactosidosaccharoses sulfates utiles notamment comme inhibiteurs du complement
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
FI961507A0 (fi) Antrasyklinonijohdannaiset ja niiden käyttö amyloidoosissa
FI930171A0 (fi) Piperidinfoereningar, framstaellning och anvaendning av dessa
ATE232386T1 (de) Neue endiyn-chinonimine und verfahren zu deren herstellung und verwendung
PT90725A (pt) Processo para a preparacao de novos compostos cefem
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
IL125926A0 (en) Compounds related to the amidinium family pharmaceutical compositions containing them and uses thereof
AR029618A1 (es) Compuestos de amida , procedimientos para prepararlos, las composiciones farmaceuticas que los contienen y el uso de dichos compuestos para la fabricacion de medicamentos
IE44765L (en) N-substituted benzamides.
DE69330601D1 (de) Serotoninergische ergolin derivate
DE69525327D1 (de) Anthracyclin-derivate
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
DK624989D0 (da) Hidtil ukendte forbindelser
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
SE8303913D0 (sv) Heterocykliska foreningar
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910916

FG3A Patent granted, date of granting

Effective date: 19980513

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19991130